title: Anthracycline-based combined chemotherapy in the mouse model.
abstract: Our research was aimed at establishing if and how selenium (Se) ion, N-acetylcysteine (NAC), sodium salt of monoketocholic acid (MKH) and superoxide-dismutase (SOD), administered in the experimental animal model, could affect the possible cytotoxicity associated with anthracycline-based combined chemotherapy with doxorubicin, vincristine and prednisolone (DVP). The following biochemical parameters were investigated: the extent of lipid peroxidation (LPx), and the activity of peroxidase (Px), catalase (CAT), glutathione-peroxidase (GSHPx), and xanthine-oxidase (XOD). A statistical increase in LPx activity was obtained by SOD, MKH, DVPSe and DVPMKH. All chemotherapeutic agents reduced Px activity in a statistically significant manner. There was no statistical significance for the results regarding the effects of the administered substances on GSHPx activity. The results for DVP, SOD, MKH, DVPSOD, DVPSe and DVPMKH showed reduced XOD activity which was statistically significant, which was lowest in the case of MKH, while NAC and Se reduced the activity of this enzyme but statistically non significant. NAC, Se, DVP, MKH and DVPMKH caused a reduction in CAT activity, while DVPSOD and DVPSe caused an increase of the latter.
authors: Faculty of Sciences, Department of Chemistry, University of Novi Sad, Republic of Serbia.
authors: M
authors: M
authors: Popovic
authors: J
authors: J
authors: Kolarovic
authors: M
authors: M
authors: Mikov
authors: S
authors: S
authors: Trivic
authors: B
authors: B
authors: Kaurinovic
mesh_terms: D000111:Acetylcysteine / Q000494:pharmacology; D000704:Analysis of Variance; D000818:Animals; D018943:Anthracyclines / Q000008:administration & dosage / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D000975:Antioxidants / Q000494:pharmacology; D002374:Catalase / Q000187:drug effects; D002793:Cholic Acids / Q000494:pharmacology; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects*; D004347:Drug Interactions; D016166:Free Radical Scavengers / Q000494:pharmacology; D005979:Glutathione Peroxidase / Q000187:drug effects; D006321:Heart / Q000187:drug effects; D015227:Lipid Peroxidation / Q000187:drug effects; D008099:Liver / Q000187:drug effects; D051379:Mice; D008807:Mice, Inbred BALB C; D009195:Peroxidase / Q000187:drug effects; D011239:Prednisolone / Q000008:administration & dosage / Q000009:adverse effects; D012643:Selenium / Q000494:pharmacology; D013482:Superoxide Dismutase / Q000494:pharmacology; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects; D014969:Xanthine Oxidase / Q000187:drug effects
chemical_list: D018943:Anthracyclines; D000975:Antioxidants; D002793:Cholic Acids; D016166:Free Radical Scavengers; D014750:Vincristine; D004317:Doxorubicin; D011239:Prednisolone; D002374:Catalase; D009195:Peroxidase; D005979:Glutathione Peroxidase; D013482:Superoxide Dismutase; D014969:Xanthine Oxidase; D012643:Selenium; D000111:Acetylcysteine
references: Biochim Biophys Acta. 1999 Aug 25;1440(1):100-6
references: 10477829
references: Biochemistry. 1985 Nov 5;24(23):6406-10
references: 3002439
references: G Ital Cardiol. 1991 Jun;21(6):633-41
references: 1743445
references: FEBS Lett. 2004 Nov 19;577(3):483-90
references: 15556633
references: Biochem Pharmacol. 1988 Mar 1;37(5):881-8
references: 3345201
references: Chem Biol Interact. 2003 Mar 6;145(1):33-9
references: 12606152
references: Biochem Biophys Res Commun. 1997 Jan 13;230(2):254-7
references: 9016760
references: Mech Ageing Dev. 1996 Sep 30;90(3):195-207
references: 8898313
references: Gastroenterology. 1976 Jun;70(6):1096-1100
references: 1269869
references: Cell. 1993 Sep 24;74(6):957-67
references: 8402885
references: Cancer Res. 2000 Jun 1;60(11):2912-8
references: 10850437
references: Int J Oncol. 2002 May;20(5):949-54
references: 11956588
references: Clin Exp Pharmacol Physiol. 2003 Mar;30(3):185-8
references: 12603349
references: Biochim Biophys Acta. 1976 Oct 11;445(3):558-66
references: 974099
references: Mol Cell Biochem. 2002 Mar;232(1-2):19-26
references: 12030376
references: Free Radic Res. 2001 Nov;35(5):575-81
references: 11767415
references: J Colloid Interface Sci. 1969 Nov;31(3):382-96
references: 5357881
references: J Biol Chem. 1952 Mar;195(1):133-40
references: 14938361
references: Biomedicine. 1981 May;35(2):65-7
references: 7260239
references: J Lipid Res. 1982 Jan;23 (1):70-80
references: 7057113
references: Toxicology. 2005 Apr 1;209(1):39-45
references: 15725512
references: Exp Toxicol Pathol. 1992 Aug;44(4):169-81
references: 1392519
references: Oncol Res. 2004;14(10):469-74
references: 15559760
references: Drug Saf. 1996 Dec;15(6):406-29
references: 8968695
references: Anticancer Drugs. 1994 Feb;5(1):3-9
references: 8186426
references: Cell. 1994 Aug 26;78(4):539-42
references: 8069905
references: Thyroid. 2004 Apr;14(4):263-70
references: 15142359
references: Chem Res Toxicol. 2002 Jan;15(1):1-6
references: 11800590
references: Carcinogenesis. 1985 Dec;6(12):1735-45
references: 3905042
references: Blood. 2000 Jun 1;95(11):3310-22
references: 10828010